Rahko

Description

Rahko is making drug discovery faster and cheaper today with quantum-inspired machine learning, and vastly more powerful and accurate tomorrow with quantum computing. Rahko was recently acquired by Odyssey Therapeutics, a biotech company pioneering next gen immunomodulators and oncology medicine.

Founded

Rahko2018

Located

RahkoLondon, United Kingdom

Technology

RahkoQuantum Machine Learning

Key People

RahkoFounders: Leonard Wassnig, Edward Grant

Key People: Leonard Wassnig, Edward Grant, Shuxiang Cao, Hongxiang Chen,

www.rahko.ai

Keys

Funding & Growth

  • Fledgling – Under 5M funding
  • Start-Up – 5M to 100M funding
  • Small Cap – 100M to 500M funding
  • Enterprise – Over 500M funding or Public

Disclaimer

Quantum Zeitgeist does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed or relying on information within this website, you should always consult with a licensed financial advisor. Any analysis we provide is for informational purposes only and does not take into consideration your circumstances or other factors that may be important in making decisions. It should not be considered an individualized recommendation or personalized investment advice. Any investment vehicles, stocks, securities mentioned may not be suitable for all investors.